scispace - formally typeset
Open AccessJournal ArticleDOI

Altering the tropism of lentiviral vectors through pseudotyping.

Reads0
Chats0
TLDR
This review samples a few of the more prominent examples from the ever-expanding list of published lentiviral pseudotypes, noting comparisons made with pseudotypes involving VSV-G in terms of titer, viral particle stability, toxicity, and host-cell specificity.
Abstract
The host range of retroviral vectors including lentiviral vectors can be expanded or altered by a process known as pseudotyping Pseudotyped lentiviral vectors consist of vector particles bearing glycoproteins (GPs) derived from other enveloped viruses Such particles possess the tropism of the virus from which the GP was derived For example, to exploit the natural neural tropism of rabies virus, vectors designed to target the central nervous system have been pseudotyped using rabies virus-derived GPs Among the first and still most widely used GPs for pseudotyping lentiviral vectors is the vesicular stomatitis virus GP (VSV-G), due to the very broad tropism and stability of the resulting pseudotypes Pseudotypes involving VSV-G have become effectively the standard for evaluating the efficiency of other pseudotypes This review samples a few of the more prominent examples from the ever-expanding list of published lentiviral pseudotypes, noting comparisons made with pseudotypes involving VSV-G in terms of titer, viral particle stability, toxicity, and host-cell specificity Particular attention is paid to publications of successfully targeting a specific organ or cell types

read more

Citations
More filters
Journal ArticleDOI

Production and purification of lentiviral vectors

TL;DR: This protocol describes how lentiviral vectors can be produced, purified and titrated for in vitro and in vivo gene delivery.
Journal ArticleDOI

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

TL;DR: Recent advances of the three major genome editing technologies are reviewed and the applications of their derivative reagents as gene editing tools in various human diseases and potential future therapies are discussed, focusing on eukaryotic cells and animal models.
Journal ArticleDOI

Engineering targeted viral vectors for gene therapy

TL;DR: Substantial progress in modifying viral vectors using diverse techniques now allows targeting to many cell types in vitro and, although important challenges remain for in vivo applications, the first clinical trials with targeted vectors have already begun to take place.
Journal ArticleDOI

Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.

TL;DR: Improved protocols to generate highly concentrated lentiviral vector pseudotypes involving different envelope glycoproteins are described, which result in high-titer vector preparations that show reduced toxicity compared with lentIViral vectors produced using standard protocols involving ultracentrifugation-based methods.
Journal ArticleDOI

LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus

TL;DR: It is shown that the LDL receptor (LDLR) serves as the major entry port ofVSV and of VSV-G-pseudotyped lentiviral vectors in human and mouse cells, whereas other LDLR family members serve as alternative receptors.
References
More filters
Journal ArticleDOI

Construction and Molecular Analysis of Gene Transfer Systems Derived from Bovine Immunodeficiency Virus

TL;DR: A gene transfer systems based on a nonprimate lentivirus, bovine immunodeficiency virus is constructed for gene therapy applications where the target cell does not divide and infection of nondividing human cells was observed.
Journal ArticleDOI

Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells.

TL;DR: The results indicate that gammaretrovirus pseudotypes from STAR cells are relatively stable at 37°C and are resistant to inactivation by freeze/thaw cycling or incubation with human sera, but HIV-1(VSV-G) was, however, sensitive to freeze/ thaw when harvested in serum-free media and was readily inactivated in human serA.
Journal ArticleDOI

Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.

TL;DR: The purification of lentiviral vectors from large-scale preparations by anion exchange chromatography allowed us to concentrate the virus to small volumes and to use these preparations to genetically modified target cells in vivo without signs of acute inflammatory responses.
Journal ArticleDOI

Selective Transduction of Malignant Glioma by Lentiviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoproteins

TL;DR: Compared the transduction efficacy of LCMV-GP- and vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentiviral vectors for malignant glioma cells and normal brain cells in vitro and in vivo, lentivir vectors pseudotyped withLCMV glycoproteins represent an attractive option for gene therapy of malignantglioma.
Journal ArticleDOI

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.

TL;DR: In this article, the gp64 envelope glycoprotein from baculovirus was used to pseudotype lentiviral vectors, which is an alternative to vesicular stomatitis virus (VSV-G).
Related Papers (5)